THERAPEUTIC EFFICACY OF LEVONORGESTREL INTRAUTERINE SYSTEM AS AN ALTERNATIVE TO HYSTERECTOMY FOR MANAGEMENT OF HEAVY MENSTRUAL BLEEDING IN PERIMENOPAUSAL WOMEN

Authors

  • Sudershan Dash Department of Obstetrics and Gynecology, PBMH, KIMS, Bhubaneswar, Odisha, India.
  • Jagannath Mishra Department of Obstetrics and Gynecology, PBMH, KIMS, Bhubaneswar, Odisha, India.
  • Shashis Shankar Behera Department of Obstetrics and Gynecology, PBMH, KIMS, Bhubaneswar, Odisha, India.
  • Subhashree Rout Department of Obstetrics and Gynecology, AIIMS,Bhubaneswar, Odisha, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i3.22363

Keywords:

Production of chloroform by fresh water chlorella species and blue green alga Anabaena flos-aquae has also been reported by Wachter and Andelman, 1984

Abstract

 Objective: This prospective observational study has been conducted to find out the efficacy and patient satisfaction of levonorgestrel intrauterine system (LNG-IUS), and it was compared with results of hysterectomy in perimenopausal Indian women with heavy menstrual bleeding (HMB).

Methods: It was a prospective study conducted on 135 cases after taking consent. Patients were inserted with LNG-IUS, and the outcome in terms of further bleeding and quality of life was compared to that of hysterectomy.

Results and Conclusion: Levonogestrol containing-IUS is a highly effective treatment of HMB in perimenopausal women. It is a safe, effective, and quality of life after treatment makes it a good alternative to hysterectomy for HMB.

Downloads

Download data is not yet available.

Author Biography

Sudershan Dash, Department of Obstetrics and Gynecology, PBMH, KIMS, Bhubaneswar, Odisha, India.

obs & gyn

professor

References

Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD, et al. Menorrhagia I: Measured blood loss, clinical features, and outcome in women with heavy periods: A survey with follow-up data. Am J Obstet Gynecol 2004;190:1216-23.

Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3-13.

Sushil K, Antony ZK, Mohindra V, Kapur A. Therapeutic use of LNG intrauterine system (Mirena) for menorrhagia due to benign lesions-analternative to hysterectomy? J Obstet Gynecol India 2005;55:541-3.

Royal College of Obstetricians and Gynaecologists. National Collaborating Centre for Women’s and Children’s Health. Heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists; 2007 (Guideline CG44).

Health Technology Assessment No. 19.88. on Behalf of the ECLIPSE Collaborative Group. Southampton (UK): NIHR Journals Library; 2015

David A, Grinces, Parker K, Jones. A clinical guide to LNG-IUS uses. Philadelphia: Lippincott Williams & Wilkins; 2001

El-Hemaidi I, Gharaibeh A, Shehata H. Menorrhagia and bleeding disorders. Curr Opin Obstet Gynecol 2007;19:513-20.

Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkilä A, Walker JJ, Cameron IT, et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105:592-8.

Tang GW, Lo SS. Levonorgestrel intrauterine device in the treatment of menorrhagia in chinese women: Efficacy versus acceptability. Contraception 1995;51:231-5.

Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690-4.

Barrington JW, Simpkins P. The LNG-IUS for management of menorrhagia. BJOG Int J Obst Gynaecol 1997;104:614-6.

Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426-9.

Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O, et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-63.

Scholten PC, Christaens GC, Haspel AA. Treatment of menorrhagia by LNG-IUS. Clininal Performance and Impact on Menstruation. Netherlands: Uterecht University Hospital; 1989. p. 47-55.

Garg S, Soni A. A Non- surgical lifeline for Abnormal uterine bleeding (AUB)-the LNG IUS. Indian J Obstet Gynecol Res 2016;3:23-7.

Yazbeck C, Omnes S, Lavenu VM, Madelenat P. Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study. Gynecol Obstet Fertil 2006;34:906-13.

Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2016;1:CD003855.

Published

01-03-2018

How to Cite

Dash, S., J. Mishra, S. Shankar Behera, and S. Rout. “THERAPEUTIC EFFICACY OF LEVONORGESTREL INTRAUTERINE SYSTEM AS AN ALTERNATIVE TO HYSTERECTOMY FOR MANAGEMENT OF HEAVY MENSTRUAL BLEEDING IN PERIMENOPAUSAL WOMEN”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 3, Mar. 2018, pp. 289-92, doi:10.22159/ajpcr.2018.v11i3.22363.

Issue

Section

Original Article(s)